Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Interest & Investment Income of $1.9 million for Q1 2026, down 72.01% year-over-year from $6.9 million in Q1 2025, and down 15.9% quarter-over-quarter from $2.3 million in Q4 2025.
Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026) Analysis & Trends
Pacira BioSciences' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 72.01% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $17.8 million (down 21.67% YoY), while the FY2025 annual figure was $22.7 million, up 15.46% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.9 million, down from $2.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $8.5 million in Q3 2025, with the low at $252000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $3.1 million (2023), against an average of $3.5 million.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income surged 3381.25% in 2022, then tumbled 72.01% in 2026.
- Pacira BioSciences' Interest & Investment Income stood at $2.8 million in 2022, then rose by 22.98% to $3.4 million in 2023, then soared by 62.19% to $5.6 million in 2024, then tumbled by 58.69% to $2.3 million in 2025, then slipped by 15.9% to $1.9 million in 2026.
- Business Quant data shows PCRX's Interest & Investment Income at $1.9 million in Q1 2026, $2.3 million in Q4 2025, and $8.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 8.53 Mn |
| Jun 30, 2025 | 5.01 Mn |
| Mar 31, 2025 | 6.90 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 177,000.00 |